Bruker Corporation provided revenue guidance for the second quarter 2022. For the second quarter of 2022, outlook is for organic revenue growth in the mid- to high single digits year-over-year, subject, of course, to further COVID-related lockdowns in China or other geopolitical risks, which could negatively impact that growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.52 USD | +3.53% | -10.76% | -1.31% |
05-02 | Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance | MT |
05-02 | Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.31% | 10.18B | |
+8.06% | 218B | |
+6.94% | 184B | |
+13.54% | 135B | |
-0.27% | 62.38B | |
+11.59% | 51.37B | |
+7.76% | 50.9B | |
+1.14% | 40.87B | |
+3.21% | 36.28B | |
+26.11% | 31.88B |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- Bruker Corporation Provides Revenue Guidance for the Second Quarter 2022